Basics ANI Pharmaceuticals, Inc. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. IPO Date: July 18, 2013 Sector: Healthcare Industry: Pharma Market Cap: $2.07B Activated in VL: True Average Daily Range Avg Daily Range: $0.91 | 2.05% Avg Daily Range (30 D): $1.10 | 1.42% Avg Daily Range (90 D): $1.05 | 1.51% Institutional Daily Volume Avg Daily Volume: .14M Avg Daily Volume (30 D): .49M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 45 Institutional Trades Total Inst.Trades: 2,143 Avg Inst. Trade: $1.94M Avg Inst. Trade (30 D): $4.01M Avg Inst. Trade (90 D): $3.15M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.31M Avg Closing Trade (30 D): $6.66M Avg Closing Trade (90 D): $4.41M Avg Closing Volume: 39.34K     News Aug 29, 2025 @ 12:00 PM CG Oncology’s Executive Leadership to Parti... Source: Cg Oncology Aug 8, 2025 @ 12:25 PM Cg Oncology (CGON) Q2 Loss Widens 93% Source: Jesterai May 12, 2025 @ 10:30 PM ANI Pharmaceuticals to Participate at the H.C. Wai... Source: N/A Feb 28, 2025 @ 3:37 PM ANI Pharmaceuticals Expects Strong Start To 2025, ... Source: Vandana Singh Oct 30, 2024 @ 9:00 PM ANI Pharmaceuticals to Discuss Third Quarter 2024 ... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.75 $.37 $.7 Diluted EPS $-.77 $.36 $.69 Revenue $ 747.4M $ 211.37M $ 197.12M Gross Profit $ $ $ Net Income / Loss $ -10.21M $ 8.55M $ 15.68M Operating Income / Loss $ 15.19M $ 13.89M $ 26.19M Cost of Revenue $ $ $ Net Cash Flow $ -22.28M $ 68M $ 4.94M PE Ratio     Splits Jul 18, 2013:   1:6 Jun 04, 2012:   1:6 Jun 03, 2002:   1:10